Show simple item record

dc.contributor.authorPozzilli, Pen_US
dc.contributor.authorLeslie, RDen_US
dc.contributor.authorPeters, Aen_US
dc.contributor.authorBuzzetti, Ren_US
dc.contributor.authorMilicevic, Zen_US
dc.contributor.authorPavo, Ien_US
dc.contributor.authorLebrec, Jen_US
dc.contributor.authorMartin, Sen_US
dc.contributor.authorSchloot, Nen_US
dc.date.accessioned2020-10-22T15:54:00Z
dc.date.issued2017-06-01en_US
dc.identifier.issn0012-1797en_US
dc.identifier.urihttps://qmro.qmul.ac.uk/xmlui/handle/123456789/67719
dc.format.extentA287 - A287en_US
dc.titleReduction of A1c with Dulaglutide in Type 2 Diabetes (T2D) Patients Positive or Negative for GAD Antibodies (GADA): A Post-hoc Analysis of AWARD-2,-4, and-5en_US
dc.typeConference Proceeding
pubs.author-urlhttp://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000408064102193&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=612ae0d773dcbdba3046f6df545e9f6aen_US
pubs.notesNot knownen_US
pubs.publication-statusPublisheden_US
pubs.volume66en_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record